Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-059341
Filing Date
2011-11-01
Accepted
2011-11-01 08:01:09
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25716_110q.htm 10-Q 1058930
2 EX-10.35 a11-25716_1ex10d35.htm EX-10.35 40741
3 EX-31.1 a11-25716_1ex31d1.htm EX-31.1 13553
4 EX-31.2 a11-25716_1ex31d2.htm EX-31.2 12737
5 EX-32.1 a11-25716_1ex32d1.htm EX-32.1 6977
  Complete submission text file 0001104659-11-059341.txt   3344896

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rigl-20110930.xml EX-101.INS 449810
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rigl-20110930.xsd EX-101.SCH 11691
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rigl-20110930_cal.xml EX-101.CAL 28575
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rigl-20110930_lab.xml EX-101.LAB 182317
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rigl-20110930_pre.xml EX-101.PRE 90312
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rigl-20110930_def.xml EX-101.DEF 58480
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 111169770
SIC: 2834 Pharmaceutical Preparations